Stock DEST DESTINY PHARMA PLC
Add to a list
To use this feature you must be a member
Log inSign up

News Destiny Pharma plc

Equities

DEST

GB00BDHSP575

Delayed London S.E.
Other stock markets
 08:04:14 2024-04-29 EDT 		5-day change 1st Jan Change
17.7 GBX +8.92% Intraday chart for Destiny Pharma plc -23.04% -74.71%
04-25 Norcros sells Johnson Tiles UK; Trifast trading well AN
04-25 Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Norcros sells Johnson Tiles UK; Trifast trading well
AN
Transcript : Destiny Pharma plc, 2023 Earnings Call, Apr 25, 2024
AIM WINNERS & LOSERS: Kromek jumps 14% on US government contract
AN
Destiny Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023
CI
EARNINGS AND TRADING: STV raises holding in Two Cities Television
AN
Destiny Pharma to Advance Skin, Colon Infection Therapies After Positive Evaluations
MT
Destiny Pharma plc Announces Clinical Development Update Positive Results from XF-73 Dermal Safety Study
CI
Destiny Pharma seeks to capitalise on XF-73 market potential in 2024
AN
Destiny Pharma Says Talks Ongoing with Potential Partners for Nasal Asset
MT
Destiny Pharma celebrates study findings on "potent" flagship drug
AN
AIM WINNERS & LOSERS: Destiny Pharma posts "landmark" XF-73 data
AN
Destiny Pharma plc Announces the Publication of New Microbiological Data on Xf-73 (Exeporfinium Chloride), Its Leading Antibacterial Drug,In Frontiers in Cellular and Infection Microbiology
CI
Dianomi swings to loss; Epwin revenue up
AN
Destiny Pharma : Interim results for the six months ended 30 June 2023
PU
Earnings Flash (DEST.L) DESTINY PHARMA Reports H1 Loss GBX-3.10
MT
Destiny Pharma plc Reports Earnings Results for the Half Year Ended June 30, 2023
CI
MGC Pharmaceuticals granted psilocybin import permit
AN
Destiny Pharma plc Announces the Publication of New Data in the Journal Infection & Drug Resistance from A Study Evaluating the Pfficacy of Xf-73
CI
FTSE 100 Closes Tuesday Up 0.2% Lifted by Unilever, Miners
DJ
Destiny Pharma says former Chair Nigel Rudd return to role
AN
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DEST Stock
  4. News Destiny Pharma plc